Relay Therapeutics, Inc. (RLAY)
19.76
+0.32
(+1.65%)
USD |
NASDAQ |
Aug 24, 16:00
19.76
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Debt to Equity Ratio : 0.0344 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0344 |
| March 31, 2026 | 0.0492 |
| December 31, 2025 | 0.0572 |
| September 30, 2025 | 0.0548 |
| June 30, 2025 | 0.0514 |
| March 31, 2025 | 0.0654 |
| December 31, 2024 | 0.0624 |
| September 30, 2024 | 0.0594 |
| June 30, 2024 | 0.075 |
| March 31, 2024 | 0.0701 |
| December 31, 2023 | 0.0711 |
| September 30, 2023 | 0.0701 |
| June 30, 2023 | 0.0688 |
| March 31, 2023 | 0.0642 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0608 |
| September 30, 2022 | 0.0603 |
| June 30, 2022 | 0.0282 |
| March 31, 2022 | 0.0267 |
| December 31, 2021 | 0.0255 |
| September 30, 2021 | 0.0408 |
| June 30, 2021 | 0.0383 |
| March 31, 2021 | 0.0329 |
| December 31, 2020 | 0.032 |
| September 30, 2020 | 0.0335 |
| June 30, 2020 | 0.0776 |
| March 31, 2020 | 0.0732 |
| December 31, 2019 | 0.0695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Insmed, Inc. | 0.9865 |
| United Therapeutics Corp. | 0.00 |
| AbbVie, Inc. | -11.93 |
| TG Therapeutics, Inc. | 1.249 |
| Travere Therapeutics, Inc. | 25.16 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 967.46M |
| Total Liabilities (Quarterly) | 77.45M |
| Shareholders Equity (Quarterly) | 890.01M |
| Current Ratio | 18.27 |
| Net Debt Paydown Yield | 0.08% |